Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Jan 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 95824901000001114 | Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 105549601000001118 | Cresemba 200mg powder for concentrate for solution for infusion vials (Pfizer Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator | EMA (European Medicines Agency) monitoring | false | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Is a | Isavuconazole 200mg powder for solution for infusion vials | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has active ingredient | Substance with triazole structure and antifungal mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has specific active ingredient | Isavuconazonium sulfate | false | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has dispensed dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Isavuconazole | false | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Is a | Cresemba | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has manufactured dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has specific active ingredient | Isavuconazonium sulfate | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has basis of strength substance | Isavuconazole | false | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has basis of strength substance | Isavuconazole | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Isavuconazole | true | Inferred relationship | Existential restriction modifier | ||
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Has dispensed dose form | Powder for conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) 1 vial | Has AMP | True | Cresemba 200mg powder for concentrate for solution for infusion vials (Basilea Pharmaceutica International Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR